Results 101 to 110 of about 9,032 (208)
Steroid Treatment Focused Management of Graves’ Ophthalmopathy
Acta Medica BulgaricaGraves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis.
Condeng Y. H. +5 more
doaj +1 more source
Update on the medical treatment of Graves’ ophthalmopathy
International Journal of General Medicine, 2009 Gregory J Griepentrog, James A GarrityDepartment of Ophthalmology, Mayo Clinic, Rochester, MN, USAPurpose: To review recent advances in the understanding of Graves’ ophthalmopathy (GO) pathogenesis as well as discuss current and future medical ...
Gregory J Griepentrog, James A Garrity
doaj
, 2015 El síndrome metabólico es un conjunto de factores de riesgo, que requieren la presencia de obesidad de predominio central, dislipemia, hipertensión arterial y resistencia a la insulina, todos ellos, predictores de enfermedad cardiovascular y diabetes ...
Güemes-Hidalgo, M., Muñoz-Calvo, M. T.
core +1 more source
Hyperthyroid heart disease: Diagnostic and therapeutic aspects [PDF]
, 1990 Reinwein, Dankwart +2 more
core +1 more source
TEMPORAL RELATIONSHIP BETWEEN THE ONSET OF THYROID DERMOPATHY AND GRAVES' OPHTHALMOPATHY
Acta Medica Iranica, 1993 Pretibial myxedema is an uncommon manifestation of Graves' disease and because of its rarity, information regarding its natural course and its relationship with other manifestations of Graves' disease is not sufficient.
Mohammad Pajhouhi
doaj
Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement. [PDF]
, 2015 Bartalena L +4 more
core +1 more source
Immunomodulators in Graves' ophthalmopathy: a systematic review. [PDF]
Front Endocrinol (Lausanne)Yeung A +9 more
europepmc +1 more source